Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Assessment of Response to Neo-Adjuvant Chemotherapy in Breast Cancer
Status: Completed
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to determine if new methods of MRI imaging can better measure participants' response to chemotherapy treatment.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Biopsy proven cases of breast cancer
Locations
United States
Ohio
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland
Time Frame
Start Date: 2019-01-14
Completion Date: 2023-04-01
Participants
Target number of participants: 14
Treatments
Experimental: 3D MR Fingerprinting scan
Three separate 3D MR fingerprinting scans: Before the start of chemotherapy, 7-10 days after the first cycle of chemotherapy, and within 1 month of the end of chemotherapy treatment.
Authors
Gulani Gulani, Vikas Gulani
Related Therapeutic Areas
Sponsors
Leads: Case Comprehensive Cancer Center